Details of the Drug Formulations

General Information of Drug (ID: DMB1N6P)

• Drug Name: Impoyz Drug Info
• Synonyms: Clobetasol propionate; CLOBETASOL PROPIONATE; 25122-46-7; Clobetasol 17-propionate; Clobex; Temovate; Dermovate; Embeline; Embeline E; Clobesol; Cormax; Olux; Temovate E; Olux-E; clobetasol 17-propanoate; GR 2/925; C25H32ClFO5; MLS000028708; Clobestasol propionate; Clobetasol propionate [USAN:JAN]; CGP 9555; CCI 4725; EINECS 246-634-3; 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; UNII-779619577M; [(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12

Indication

Disease Entry	ICD 11	Status	REF
Scalp dermatosis		Approved	[1]
Plaque psoriasis	EA90.0	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 32798
  ChEBI ID: CHEBI:31414
  CAS Number: 25122-46-7
  TTD ID: D0H0YD
  INTEDE ID: DR0344
  ACDINA ID: D00954

Full List of Drug Formulations Containing This Drug

Clobetasol Propionate 0.05% aerosol

Company	Formulation ID	FDA Description
Taro Pharmaceuticals U.S.A.	F23047	Cetyl Alcohol; Citric Acid Anhydrous; Dehydrated Alcohol; Polysorbate 60; Potassium Citrate; Propylene Glycol; Purified Water; Stearyl Alcohol; Hydrocarbon; Propane; Butane

References

• [1] Post-traumatic erosive dermatosis of the scalp: A?hypergranulated variant. Australas J Dermatol. 2019 Nov;60(4):e322-e326.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)